Test
Start the ReDirection program
Are you struggling with your use or urges to use sexual images or videos depicting children?
ReDirection is an anonymous self-help program which aims to help you adopt a lifestyle without child sexual abuse material (CSAM). This program will support you to take control of your emotions, thoughts and behavior in order to ‘ReDirect’ you away from using CSAM.
Child Sexual Abuse Material (CSAM) is sometimes referred to as child pornography. CSAM includes images, videos, live-streaming, and any other material that depicts sexual acts with a child or adolescent (i.e., a person under the age of 18). CSAM also includes material that shows a child or adolescent in a sexually suggestive or explicit manner partially clothed, or nude, and can include material that does or does not illustrate sexual activity.
The ReDirection program is currently being offered through a research project as there is a great need for more knowledge to support individuals who are concerned about their use or urges to use CSAM. This is why we are recruiting for a clinical trial where participants will be randomly assigned to one of two versions of the ReDirection program, or to a waitlist before accessing the ReDirection program. The overall goal for this research project is to help you to reduce the use of CSAM by developing better and more efficient therapeutic interventions for persons who are concerned about their use or urges to use CSAM.
Want to make a difference? Start the ReDirection program today and learn to take control of your thoughts and behavior.
Is this research project right for me?
You are eligible to participate in this research project if:
You are 18 years or older
You can read and write in English or Spanish
You have used CSAM in the last six months OR you have experienced urges (also defined as impulses, desires, compulsions, cravings) to use CSAM within the last six months
A walk through the ReDirection project
Registration, information, consent and login
Recruitment runs from January 15, 2025 to July 15, 2025. You can easily register by clicking on the Registration button above. After reading the information about the study, you will be asked to give your consent to participate. At this point, you will create your login details.
Online questionnaires
Before, during, and after the program, you will be asked to complete a number of questionnaires. The purpose of this is to collect information about participants to evaluate the program.
The ReDirection program
You will be randomly offered one of the two versions of ReDirection that we are evaluating, but we cannot influence which intervention you are offered. The primary difference between the two versions of ReDirection is the length of the program and whether it includes the option for asynchronous messaging with a ReDirection specialist.
Waitlist
In this clinical trial, we are comparing against a waitlist control. This means that when the participants are included in the study, they have an equal chance of either being included directly into one of two versions of ReDirection or being placed on a waiting list before being able to join an intervention. While on the waitlist, participants will still receive requests to fill in weekly questionnaires. After this period, participants will access the intervention they are offered. This process is used so that we can thoroughly test our interventions in order to ensure high quality and effective interventions. The participants that are randomized to the waiting list will receive the program after six weeks.
Treatment alternatives
At the end of the ReDirection program, you will be provided recommendations for alternative treatments if you need further professional support. A list of “Other Organizations” is also available below.
Safety
ReDirection is anonymous and accessible via Tor browser, prioritizing the privacy of all participants.
Cost
ReDirection is free of charge.
Study Information:
This study (study title: Evaluation of an Online Self-Help Program for CSAM) has been reviewed and approved by the Royal Ottawa Health Care Group Research Ethics Board (REB) as study #0246.
Principal Investigator: Dr. Carissa Augustyn.
Any questions so far?
If you have any questions, or are thinking about participating but are unsure of what it entails, you are warmly welcome to email us at